Metabolically Healthy Obesity: Correlations Between BMI and Metabolic Syndrome Biomarkers
1 other identifier
observational
691
1 country
1
Brief Summary
The study team's research fills the gap in the obesity literature where BMI with a cut point of 35 is frequently used to show the association between BMI and metabolic syndrome biomarkers. The study team was unable to locate any papers that showed the association between metabolic syndrome biomarkers and BMI from 35 to 69.9, and especially graphically as this clinical team has presented.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 4, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2016
CompletedFirst Submitted
Initial submission to the registry
June 9, 2017
CompletedFirst Posted
Study publicly available on registry
June 22, 2017
CompletedJune 22, 2017
June 1, 2017
4.1 years
June 9, 2017
June 19, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The association between BMI from 35 - 69.9 and Total cholesterol
The statistical association between a range of BMIs from 35 to 69.9 kg/m2 and total cholesterol reported in mg/dl. Blood draw was performed at an independent lab as prescribed by the patients' private physician and reported to the weight loss program at Mount Sinai St. Luke's Hospital prior to the patient starting the program. To determine the association between the BMIs and total cholesterol a linear regression analysis was performed and reported graphically. The regression equation, R2, and the p-value for the regression were presented on the graph.
7 years
Secondary Outcomes (7)
The association between BMI from 35 - 69.9 and HDL- cholesterol
7 years
The association between BMI from 35 - 69.9 and LDL- cholesterol
7 years
The association between BMI from 35 - 69.9 and Triglycerides
7 years
The association between BMI from 35 - 69.9 and Systolic Blood Pressure
7 years
The association between BMI from 35 - 69.9 and Diastolic Blood Pressure
7 years
- +2 more secondary outcomes
Study Arms (1)
Patients with Class II and III Obesity
Patients enrolled in an outpatient weight loss program from 2010-2016.
Eligibility Criteria
BMI 35- 69.9 Men and Women over age 25
You may qualify if:
- BMI in the range of 35 - 69.9
- Men and Women over age 25
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mount Sinai St, Luke's
New York, New York, 10025, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Weil, M.Ed
Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2017
First Posted
June 22, 2017
Study Start
September 4, 2012
Primary Completion
September 30, 2016
Study Completion
September 30, 2016
Last Updated
June 22, 2017
Record last verified: 2017-06